您要查找的是不是:
- Liver X receptors agonists 肝X受体激动剂
- Liver X receptor agonist 肝x受体激动剂
- Keywords ATP-binding cassette transporter A1;Liver X receptor;Atherosclerosis;Proinflammatory gene;Reverse cholesterol transport; 三磷酸腺苷结合盒转运体A1;肝X受体;动脉粥样硬化;促炎基因;逆向胆固醇转运;
- liver X receptors 肝X受体
- Liver X Receptors( LXRα) LXRα
- Liver X receptor 肝X受体
- Liver X receptor alpha 肝X受体α
- Liver X receptor α 肝脏肝X受体α
- The M receptor agonist pilocarpine was similar to the effects of ACh. M受体激动剂毛果芸香碱能产生与ACh相似的效应。
- Background Ergot-derived dopamine receptor agonists, often used in the treatment of Parkinson's disease, have been associated with an increased risk of valvular heart disease. 背景:有发现表明常用于治疗帕金森病的麦角洐生的多巴胺受体激动剂可增加发生瓣膜性心脏病的风险。
- Objective To study the effect of 5-HT1A receptor agonists Urapidil on lengthening survival time of dogs in a hot and humid environment. 目的探讨5-HT1A受体激动剂乌拉地尔在高温高湿环境下延长生存时间的保护作用。
- Objective To investigate the effect of doparnine receptor agonist piribedil on dopamine transporter. 目的研究常用抗帕金森药多巴胺受体激动剂吡贝地尔(舒达)脑多巴胺转运体的影响。
- Clinical treatment of PD includes dopamine replacement such as L-DOPA and D_2 dopamine receptor agonist. 目前临床仍以替代治疗为主,左旋多巴和D_2受体激动剂能改善PD症状,但不能阻制疾病发展,这使人们对PD治疗的认识由单纯替代疗法逐渐转向保护中脑DA能神经元。
- Background Ergot-deried dopamine receptor agonists, often used in the treatment of Parkinson's disease, hae been associated with an increased risk of alular heart disease. 背景:有发现表明常用于治疗帕金森病的麦角洐生的多巴胺受体激动剂可增加发生瓣膜性心脏病的风险。
- DEX is a typical inducer of CYP3A4, by a pregnane X receptor (PXR) mediated mechanism. DEX是典型的CYP3A4诱导剂,其诱导机制由PXR介导。
- Rotigotine is a non-ergolinic dopamine receptor agonist available as a patch for once-daily use. 罗替戈汀是现有非二氢麦角碱多巴胺受体激动剂中可作为每日一次使用的辅助药物。
- Rotigotine is a non-ergolinic dopamine receptor agonist aailable as a patch for once-daily use. 罗替戈汀是现有非二氢麦角碱多巴胺受体激动剂中可作为每日一次使用的辅助药物。
- Their regulation is implemented through interaction between two types of nuclear receptors: retinoic acid receptor(RAR)and retinoid X receptor(RXR). 其调节作用是通过两种核受体的相互作用实现的:视黄酸受体和类视黄醇X受体。
- The citrated whole blood is tested at the basal and TRAP (Thrombin Receptor Agonist Peptide) activated states. 柠檬酸化的健康的血被测试在基础并且捕捉(凝血酶感受器官收缩筋肽)被激活的状态。
- Results and Conclusions H4 receptor agonists and antagonists have a strong biological activity.With the study progressing, novel drugs for clinical medicine may be developed. 结果与结论:H4受体激动剂及拮抗剂具有很强的生物活性,随着对H4受体配体研究的深入,有希望开发出可用于临床的新药物。